# Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.

> **NCT05827536** · NA · TERMINATED · sponsor: **APR Applied Pharma Research s.a.** · enrollment: 21 (actual)

## Conditions studied

- Phenylketonurias

## Interventions

- **DIETARY_SUPPLEMENT:** PKU GOLIKE
- **DIETARY_SUPPLEMENT:** Standard of Care

## Key facts

- **NCT ID:** NCT05827536
- **Lead sponsor:** APR Applied Pharma Research s.a.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-10-30
- **Primary completion:** 2024-11-27
- **Final completion:** 2024-11-27
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Due to recruitment challenges, and despite an extension of the study period, the decision to terminate the trial early was made in agreement with the Principal Investigator
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05827536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05827536, "Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT05827536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*